Company: CDLX
Filing Date: 2025-04-29
Form Type: DEFR14A
Source: 0001666071-25-000062
Chunk: 0

Company: Cardlytics, Inc.
Filing Date: 2025-04-29
Form: DEFR14A
Chunk 0
---
### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### WASHINGTON, DC 20549

#### SCHEDULE 14A
<div align='center'>Proxy Statement Pursuant to Section 14(A) of the Securities Exchange Act of 1934

(Amendment No. 1 )</div>

| Filed by the Registrant                    |     | ☒ |
| Filed by a party other than the Registrant |     | ☐ |

| Check the appropriate box: |     |                                                                                 |
| ☐                          |     | Preliminary Proxy Statement                                                     |
| ☐                          |     | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☒                          |     | Definitive Proxy Statement                                                      |
| ☐                          |     | Definitive Additional Materials                                                 |
| ☐                          |     | Soliciting Materials under 240.14a-12                                           |

#### CARDLYTICS, INC.
<div align='center'>(Name of Registrant as Specified in its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</div>

| Payment of filing fee (Check all boxes that apply): |     |                                                                                                      |
| ☒                                                   |     | No fee required.                                                                                     |
| ☐                                                   |     | Fee paid previously with preliminary materials.                                                      |
| ☐                                                   |     | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |

#### Explanatory Note
We are filing the accompanying revised Definitive Proxy Statement on Schedule 14A for the sole purpose of including certain Inline eXtensible Business Reporting Language data tagging, which was inadvertently omitted from the original Definitive Proxy Statement.

Insider Trading Policy and Short-Selling, Hedging, and Pledging

We have adoptedan Insider Trading Policy governing the purchase, sale, and/or other dispositions of our securities and those of public companies in which we have a business relationship by our directors, executive officers, employees and consultants, that we believe is reasonably designed to promote compliance with insider trading laws, rules and regulations, and the exchange listing standards applicable to us. Additionally, it is our company’s intent to comply with insider trading laws, rules and regulations. A copy of our Insider Trading Policy is filed as an exhibit to our Annual Report on Form 10-K.

Under